Industry: Gene Therapy
Technology: Neurological Disorders
Funding Status: M&A
Estimated Revenue: Less than $1M
Investors Number: 12
Headquarters: Ann Arbor, Michigan, United States
Total Funding: $106M
Founded Date: 2009
Last Funding Type: Venture - Series Unknown